期刊档案 · 医学-生化与分子生物学
Journal of Huazhong University of Science and Technology-Medical Sciences
ISSN 1672-0733 · eISSN 2523-899X · PEOPLES R CHINA · Bimonthly · 创刊 2002
Journal of Huazhong University of Science and Technology-Medical Sciences 影响因子 2（官网公布），订阅期刊，近 24 个月 86 篇文章投稿到接收中位 165 天，录用比例容易（社区反馈）。
研究范围
研究范围与定位
Journal of Huazhong University of Science and Technology-Medical Sciences。按 OpenAlex 近年发文统计，该刊主要发表 RNA Interference and Gene Delivery、Immune Response and Inflammation、Immunotherapy and Immune Responses 等主题的论文，这 3 个主题约占 17.8%，主导子领域为 Molecular Biology。（根据 OpenAlex 主题统计与中科院分区数据生成）
Aims and Scope Current Medical Science, a peer-reviewed general medical journal published by Huazhong University of Science & Technology, is committed to disseminating the latest advancements in medical science. The journal focuses on original, innovative and influential research across a broad spectrum of medical fields, including medicine, biomedicine, public health, and their interdisciplinary extensions. We also publish insightful reviews, comments, as well as special topic articles. Areas of Focus Current Medical Science welcome submissions in, but not limited to, the following areas:
· Mechanisms of Human Diseases: Studies uncovering the mechanisms of human diseases, particularly those revealing pathogenesis and potential therapeutic targets.
· Clinical Trials: Research on new treatments, medications, or medical techniques, as well as evaluations of existing therapies.
· Public Health & Global Health: Investigations into disease prevention and health promotion; research that addresses pressing and emerging global health challenges including, but not limited to, antimicrobial resistance, infectious diseases, chronic conditions, and aging.
· Others: We also value insightful reviews, comments, perspectives, and encourage publications of guidelines and consensus statements that offer evidence-based recommendations to the medical community.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：医学-生化与分子生物学
主编 Jian-Guo Chen出版商官网
编委会国家分布：中国大陆 163 位（约 94%）；主要国家 中国 163、美国 6、中国香港 2、新加坡 2、英国 1（共 174 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology7.4%
- Immune Response and InflammationImmunology and Microbiology5.4%
- Immunotherapy and Immune ResponsesImmunology and Microbiology5%
- Angiogenesis and VEGF in CancerBiochemistry, Genetics and Molecular Biology4.9%
- Hepatitis B Virus StudiesMedicine4.5%
- Cell death mechanisms and regulationBiochemistry, Genetics and Molecular Biology4.2%
- Neuroscience and Neuropharmacology ResearchNeuroscience4.1%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.1%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
收录数据库：暂无记录。
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
SCIEScopusMEDLINECAS出版商官网
其他：Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、Naver、OCLC、Portico、CLOCKSS、Semantic Scholar
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布） 2025
- 2出版商官网 ·
- 五年影响因子（出版商公布） 2025
- 2.2出版商官网 ·
- CiteScore 2026-06
- 1.08LetPub ·
- SJR 2026-06
- 0LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 24LetPub ·
- h-index
- 42OpenAlex ·
- i10-index
- 744OpenAlex ·
- 两年平均被引
- 0OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
发文规模
- 年下载量（出版商公布） 2025
- 305,400出版商官网 ·
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
165 天投稿到接收中位数 · P25–P75 97 天 – 256 天
- 接收到上线
- 中位数 27 天（86 篇）
- 投稿到上线
- 中位数 193 天
- 样本
- 86 篇有投稿与接收日期的文章（窗口内共 275 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 一般,3-8周LetPub ·
- 平均录用比例（社区反馈）
- 容易LetPub ·
- 投稿到首次决定
- 15 天出版商官网 ·
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊LetPub
订阅期刊，文章需订阅或购买阅读，通常不收取版面费。
尚未从任何来源获得费用信息，请以期刊官网为准。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点4 项，摘自作者指南
- 摘要
- ≥ 150 词
- 关键词
- ≥ 4 个
- 参考文献格式
- Vancouver 格式
- 推荐审稿人
- 可选
接收的文章类型9 种，含篇幅限制
- brief reportCurrent Medical Science welcomes a variety of paper types, including original article, review, commentary, perspective, guideline, consensus article, that align…正文 ≤ 300 词 · 摘要 ≤ 300 词 · 参考文献 ≤ 20
- commentaryCurrent Medical Science welcomes a variety of paper types, including original article, review, commentary, perspective, guideline, consensus article, that align…未说明篇幅
- consensus articlesconsensus articles: Documents that reflect the collective opinion of leading experts on a particular topic, often developed through consensus meetings or collab…未说明篇幅
- editorialCurrent Medical Science welcomes a variety of paper types, including original article, review, commentary, perspective, guideline, consensus article, that align…正文 ≤ 2,000 词 · 参考文献 ≤ 10
- editorial and commentaryEditorial and Commentary: Opinion pieces that offer analysis, critique, or recommendations on recent publications or developments within the field.未说明篇幅
- guidelinesGuidelines: Articles that provide evidence-based recommendations for clinical research and practice, or public health policy.未说明篇幅
- original articleCurrent Medical Science welcomes a variety of paper types, including original article, review, commentary, perspective, guideline, consensus article, that align…正文 ≤ 400 词 · 摘要 ≤ 400 词
- perspectiveCurrent Medical Science welcomes a variety of paper types, including original article, review, commentary, perspective, guideline, consensus article, that align…正文 ≤ 300 词 · 摘要 ≤ 300 词
- reviewCurrent Medical Science welcomes a variety of paper types, including original article, review, commentary, perspective, guideline, consensus article, that align…正文 ≤ 400 词 · 摘要 ≤ 400 词
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、许可与版权、开放获取、同行评审、试验注册 / 报告规范
- AI 使用 Generative AI Images
AI-assisted copy editing does not need to be declared 模型摘要
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
原文 ↗出版商官网 ·- 作者资格 Authorship principles
LLMs do not satisfy authorship criteria 模型摘要
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
原文 ↗出版商官网 ·- 利益冲突 Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
原文 ↗出版商官网 ·- 数据可用性 Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
原文 ↗出版商官网 ·- 许可与版权 Copyright
Articles in Springer Nature open access journals do not require transfer of copyright as the copyright remains with the author. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
原文 ↗出版商官网 ·- 开放获取 Open access publishing
To find out more about publishing your work Open Access in Current Medical Science, including information on fees, funding and licences, visit our Open access publishing page. Back to top
原文 ↗出版商官网 ·- 同行评审 Double-blind peer review
Double-blind peer review 模型摘要
This journal follows a double-blind reviewing procedure. This means that the author will remain anonymous to the reviewers throughout peer review. It is the responsibility of the author to anonymize the manuscript and any associated materials. Author names, affiliations and any other potentially identifying information should be removed from the manuscript text and any accompanying files (such as …
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版国家或地区
- PEOPLES R CHINA
- 出版周期
- Bimonthly
- 创刊年份
- 2002
- ISSN
- 1672-0733
- 印刷版 ISSN
- 2096-5230
- 电子版 ISSN
- 2523-899X
- 官网最新一期
- Volume 46, Issue 4（2026 年 8 月）
- 官方链接
- 期刊主页 ↗LetPub
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Journal of Huazhong University of Science and Technology-Medical Sciences 的常见问题
Journal of Huazhong University of Science and Technology-Medical Sciences 的影响因子是多少？
期刊官网公布的影响因子为 2（2025 年度），属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 1.08，h-index 为 42。
Journal of Huazhong University of Science and Technology-Medical Sciences 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）86 篇已发表文章登记的日期，投稿到接收的中位数为 165 天（四分位 97–256 天）；投稿社区反馈的平均审稿速度为3–8 周，平均录用比例反馈为“容易”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Journal of Huazhong University of Science and Technology-Medical Sciences 的投稿格式要求是什么？
据期刊作者指南：摘要：≥ 150 词；关键词：≥ 4 个；参考文献格式：Vancouver 格式；推荐审稿人：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Journal of Huazhong University of Science and Technology-Medical Sciences 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 174 位编委中，中国大陆 163 位（约 94%）；人数最多的国家是 中国（163 位）、美国（6 位）、中国香港（2 位）。统计按编委会页面列出的机构国家计，仅供参考。
Journal of Huazhong University of Science and Technology-Medical Sciences 被哪些数据库收录？
期刊官网自述还被 SCIE、Scopus、MEDLINE、CAS 收录，该清单未与各数据库逐一核对。
Journal of Huazhong University of Science and Technology-Medical Sciences 是开放获取期刊吗？版面费多少？
Journal of Huazhong University of Science and Technology-Medical Sciences 为订阅期刊。费用信息尚未获得，请以官网为准。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。